Page 158 - Read Online
P. 158

Sobenin et al. Vessel Plus 2019;3:15  I  http://dx.doi.org/10.20517/2574-1209.2019.09                                                   Page 9 of 9

                   based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation
                   1995;92:1758-64.
               8.   Beux F, Carmassi S, Salvetti MV, Ghiadoni L, Huang Y, et al. Automatic evaluation of arterial diameter variation from vascular
                   echographic images. Ultrasound Med Biol 2001;27:1621-9.
               9.   Sobenin IA, Sazonova MA, Postnov AY, Salonen JT, Bobryshev YV, et al. Association of mitochondrial genetic variation with carotid
                   atherosclerosis. PLoS One 2013;8:e68070.
               10.  Sazonova M, Budnikov E, Khasanova Z, Sobenin I, Postnov A, et al. Studies of the human aortic intima by a direct quantitative assay of
                   mutant alleles in the mitochondrial genome. Atherosclerosis 2009;204:184-90.
               11.  Sobenin IA, Sazonova MA, Postnov AY, Bobryshev YV, Orekhov AN. Mitochondrial mutations are associated with atherosclerotic
                   lesions in the human aorta. Clin Dev Immunol 2012;2012:832464.
               12.  Lang TA, Secic M. How to report statistics in medicine: annotated guidelines for authors, editors, and reviewers. Second edition.
                   American College of Physicians, Philadelphia, 2006.
               13.  Ioannidis JP. Prediction of cardiovascular disease outcomes and established cardiovascular risk factors by genome-wide association
                   markers. Circ Cardiovasc Genet 2009;2:7-15.
               14.  Sobenin IA, Chistiakov DA, Bobryshev YV, Postnov AY, Orekhov AN. Mitochondrial mutations in atherosclerosis: new solutions in
                   research and possible clinical applications. Curr Pharm Des 2013;19:5942-53.
               15.  Yu E, Mercer J, Bennett M. Mitochondria in vascular disease. Cardiovasc Res 2012;95:173-82.
               16.  Sobenin IA, Zhelankin AV, Mitrofanov KY, Sinyov VV, Sazonova MA, et al. Mutations of mitochondrial DNA in atherosclerosis and
                   atherosclerosis-related diseases. Curr Pharm Des 2015;21:1158-63.
               17.  Sobenin IA, Zhelankin AV, Sinyov VV, Bobryshev YV, Orekhov AN. Mitochondrial aging: focus on mitochondrial DNA damage in
                   atherosclerosis - A mini-review. Gerontology 2015;61:343-9.
               18.  Sinyov VV, Sazonova MA, Ryzhkova AI, Galitsyna EV, Melnichenko AA, et al. Potential use of buccal epithelium for genetic diagnosis
                   of atherosclerosis using mtDNA mutations. Vessel Plus 2017;1:145-50.
               19.  Sazonova MA, Ryzhkova AI, Sinyov VV, Galitsyna EV, Orekhova VA, et al. New markers of atherosclerosis: a threshold level of
                   heteroplasmy in mtDNA mutations. Vessel Plus 2017;1:182-91.
               20.  Hoffmann B, Moebus S, Dragano N, Möhlenkamp S, Memmesheimer M, et al. Heinz nixdorf recall investigative group. Residential
                   traffic exposure and coronary heart disease: results from the Heinz Nixdorf Recall Study. Biomarkers 2009;14:74-8.
               21.  Orekhov AN, Ivanova EA. Introduction of the special issue "atherosclerosis and related diseases". Vessel Plus 2017;1:163-5.
   153   154   155   156   157   158   159   160   161   162   163